Esketamine: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Esketamine. Educational only — not medical advice.
Labeled uses
SPRAVATO is indicated for the treatment of: Treatment-resistant depression (TRD) in adults as monotherapy or in conjunction with an oral antidepressant Depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior in conjunction with an oral antidepressant
Source: FDA labeling via NIH DailyMed (set d81a6a79…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.